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ABSTRACT 
 
UNDERSTANDING THE ROLE OF REACTIONS TO RACE-BASED TREATMENT ON 
HIV TESTING BEHAVIORS 
 
By 
 
JOËLLE FOLSADÉ ATERE-ROBERTS 
 
May 4, 2016 
 
 
INTRODUCTION:  In the United States, Blacks and Hispanics compared to Whites are 
disproportionately infected with HIV. Testing for HIV is critical to reduce HIV 
transmission, lower risk behaviors, and improve access to treatment among persons 
living with HIV. However, racial & ethnic minorities are tested at later stages of HIV. 
Previous studies that examined racial discrimination and HIV testing reported 
inconsistent findings and additional knowledge is needed to understand whether 
differential treatment based on race is an important barrier to HIV testing. 
  
AIM: We examined whether HIV testing is influenced by how an individual reacts to 
race-based treatment, rather than experiences of discrimination alone, among Whites, 
Blacks, and Hispanics; and we determined if this relationship was modified race and 
ethnicity. 
  
METHODS: We performed a cross-sectional analysis of the 2012 Behavioral Risk 
Factor Surveillance System’s (n=12,579) self-reported HIV testing data and Reaction to 
Race (RR) module, which captures experiences of differential treatment based on race 
and an individual’s reaction to racialized treatment. Multivariable logistic regression was 
used to assess the association between RR-based treatment and HIV testing. Statistical 
interaction between RR-based treatment and race was assessed. 
  
RESULTS: Approximately 21% participants reported ever being tested for HIV, and 
19% of the participants had one or more experiences of RR-based treatment. 
Prevalence of HIV testing was higher among Blacks (62%) and Hispanics (33%) 
compared to Whites (32%). In an adjusted model, the odds of HIV testing among those 
who reported one experience of Reactions to Race based treatment was 1.37 (95% CI: 
1.08-1.75) times the odds among those with no experiences of RR-based treatment. We 
did not detect statistical interaction between RR-based treatment and HIV testing by 
race. 
  
DISCUSSION: Our findings suggest that experiences of racial discrimination may be 
counter intuitively associated with increased HIV testing overall and within each racial 
and ethnic group. Additional research is needed to clarify settings in which experiences 
of race-based treatment and the associated reactions to the treatment can positively or 
negatively influence HIV testing behaviors. 
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Chapter I- Introduction 
This thesis seeks to understand racial and ethnic disparities in HIV infection by 
examining the potential pathway through which experiences of racial discrimination can 
influence HIV testing behaviors. In the United States, Blacks and Hispanics are 
disproportionately infected with HIV compared to Whites.1 Moreover, Blacks (15%) and 
Hispanics (15%) have the highest percentage of undiagnosed HIV infections compared to 
Whites (11%).2 Existing research recognizes the critical role HIV testing plays in preventing HIV 
transmission through initiation of HIV treatment and reducing high-risk sexual and drug use 
behaviors among those who are HIV infected.3 Therefore, an understanding of HIV testing 
behaviors among Blacks and Hispanics compared to Whites is crucial to understanding 
persistent racial and ethnic disparities in HIV.  
While research has found that HIV testing rates are higher among Blacks and Hispanics 
compared to Whites,4 a high percentage of Blacks (38%) and Hispanics (52%) report that they 
have never been tested for HIV in their lifetime compared to Whites (59%)5 This suggests a 
continued need for improving HIV testing and prevention efforts among racial and ethnic 
minorities. Existing research has suggested that HIV testing barriers, for example fear of 
positive HIV status, lack of access to care, and misconceptions about HIV risk, may influence 
racial and ethnic disparities in HIV.6-9  
A separate but growing body of literature has also indicated that racial discrimination, 
defined as differential treatment based on phenotypic race, may be an important predictor of 
HIV testing and racial and ethnic disparities in HIV. Racial discrimination is associated with a 
host of poor health outcomes and behaviors, which may partially account for many racial and 
ethnic health disparities. 10-13 For example, experiences of racial discrimination among 
marginalized groups has been associated with elevated blood pressure, negative mental health 
outcomes, and increased smoking behavior.6-9 In the case of HIV testing, racial discrimination 
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results in a unique set of stressors among minorities, which triggers a response to racial stimuli 
that may negatively impact HIV testing behavior. High levels of stress are positively related to 
high-risk coping behaviors including sex and drug use and are negatively related to healthy 
behaviors including breast and prostate cancer screening.11,14-17 The pathways by which racial 
discrimination can affect HIV testing may require different operationalization of racial 
discrimination, which would result in variability in how racial discrimination is measured. 
A small body of literature on the relationship between racial discrimination and HIV 
testing, has counter intuitively shown a positive relationship where experiences of discrimination 
are associated with higher rates of HIV testing. However, the variability between the results of 
this existing literature is likely due to differences in the operationalization of discrimination. 
Different measures have been used to capture perceived acute experiences of discrimination, 
chronic experiences, and some literature with no clear distinction between the type(s) of 
discrimination being measured (Table I) 18.  
Since studies have examined the association between experiences of racial 
discrimination and HIV testing, we address gaps in the literature by examining this relationship 
in a racially diverse sample. Given the mixed results of previous studies on racial discrimination 
& HIV testing, this research is critical in understanding the pathways by which racial 
discrimination can be detrimental or constructive in regard to seeking HIV testing. This research 
adds to the literature by examining not only the experience of racial discrimination, but also the 
individuals’ reactions to the differential treatment based on race. Herein, we examined the 
association between Reactions to Race-based treatment and HIV testing behaviors within racial 
and ethnic groups; and we hypothesized that respondents who report Reactions to Race-based 
treatment have lower HIV testing prevalence and an interaction between race and ethnicity and 
Reactions to Race-based treatment with respect to HIV testing will be present. This thesis uses 
the Reactions to Race module measures, which captures 1) whether or not an individual 
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experiences racial discrimination, 2) whether an individual embodies the experiences, and 3) 
how an individual responds to race-based treatment.19 In essence, the Reactions to Race scale 
captures an individual’s experience of differential treatment based on race and whether or not 
an individual perceives that they experience a physical or emotional response to a racialized 
experience. Reactions to Race based treatment have been shown to be negatively related to 
poor self-rated health, lower breast cancer screening, lower colorectal cancer screening by 
endoscopy and digital rectal exam.20-22The next chapters delve into the existing literatures that 
assess HIV testing and health disparities, barriers to HIV testing, discrimination pathways on 
health behaviors, and the relationship between racial discrimination and HIV testing. Following 
the literature review, we will present the methods and findings of the proposed research 
question.  
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Chapter II-Literature Review 
2.1 The role of HIV testing in reducing racial and ethnic disparities in HIV. 
Racial and ethnic disparities in HIV transmission are pervasive in the US.23 Blacks 
accounted for 47% of incident HIV infections and an estimated 43% of prevalent HIV infections 
in 2012. Additionally, Hispanics represented 16% of the US population in 2012 but accounted 
for over one-fifth (21%) of the new HIV infections and 19% of individuals living with HIV.1 
National estimates have found that of approximately 1.2 million people living with HIV infection 
in the United States, about 12.8%, most of whom are Black and Hispanic, are unaware of their 
HIV status.24 Specifically, 17% of Blacks and 17% of Hispanics compared to only 13% of Whites 
(13%) have undiagnosed HIV infections.2  Knowledge of HIV status is particularly important in 
reducing HIV transmission as previous studies have shown that knowledge of HIV status is 
associated with fewer high-risk behaviors, which would lower the risk for acquiring and/or 
transmitting HIV.25,26 Individuals who are HIV-positive have increased rates of condom use 
during sex, lower rates of injection drug use, and decreased rates of sex in exchange for money 
after becoming aware of their HIV status.27-30 Knowledge of HIV status is also important 
because, once an individual is diagnosed as HIV positive s/he can be linked to care and medical 
services that can reduce morbidity, mortality and improve quality of life.31, Given this, HIV 
testing is a crucial part of HIV prevention, treatment, and care.32  
Although studies show that HIV testing rates are higher among Blacks (59.7%) and 
Latinos (45.6%) compared to Whites (42.4%)5, other data indicate important gaps in HIV testing 
among racial and ethnic minorities. For example, racial and ethnic minorities are more likely to 
be tested in later stages of infection and die from AIDS compared to whites.4 Among those with 
HIV, 31% of Blacks and 36% of Hispanics compared to 32% of whites were tested in the late 
stages of illness, which is measured by being diagnosed with AIDS within one year of testing 
HIV positive.33 This suggests an important gap in our understanding and ability to reach and test 
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racial and ethnic minorities who are farther along in the progression of HIV.34  Murray and Oraka 
conducted a study using data from the National Health Interview Survey to understand HIV 
testing intentions by race and ethnicity.35 The results revealed Whites (81%) and Asians (71%) 
had a significantly higher percentage of individuals who were never tested for HIV because they 
perceived themselves to be at low risk compared to Blacks (66%) and Hispanics (65%).  On the 
other hand, Blacks and Hispanics had higher percentages of respondents who never received a 
HIV test due to fear of HIV-related stigma compared to other races. The results of this study 
gives insight on the varying levels of perceived risk of infection across racial and ethnic groups, 
which may be important to understand decisions to not be tested for some racial and ethnic 
minorities.  
There are a number of ways that higher rates of HIV testing among racial and ethnic 
minorities might reduce high-risk behaviors to prevent transmission of the virus to others. First, 
those who test HIV positive and initiate antiretroviral treatment (ART) to achieve a suppressed 
viral load will have a lower likelihood of transmitting HIV to others.36 Furthermore, an individual 
who tests positive for HIV can identify other sexual partners who are at risk and recommend HIV 
testing and/or encourage the use of pre-exposure prophylaxis to decrease their chance of 
getting infected.37 Therefore, we should consider HIV testing not only as a diagnostic tool but 
also as an important HIV prevention strategy that could be important to reducing inequities in 
HIV by race and ethnicity.  
 
2.2 Barriers to HIV testing among racial and ethnic minorities 
The Centers for Disease Control and Prevention (CDC) recommends that adolescents 
and adults age 13-64 get tested for HIV at least once as a routine part of medical care, and 
even more frequent testing among men who have sex with men and other populations who 
engage in high risk behavior such as injection drug use and unprotected sex.34 Although the 
rates of HIV testing have increased, approximately 55% of Americans have not been tested in 
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their lifetime.38 Fear of a positive HIV diagnosis, misconceptions about HIV risk and HIV testing 
procedures, and lack of access to healthcare are key barriers to increasing HIV testing.38 In a 
study on barriers to HIV testing among Hispanics, Lopez-Quintero et al found 75% of 
participants reported “not considering oneself to be at risk” as the primary reasons for not 
getting tested.39 However, the study did not consider other social factors such as access to 
healthcare, discrimination, socioeconomic status etc. that could also influence respondents’ 
reason for not being tested. In another study using data from the Web-based HIV Behavioral 
Surveillance (WHBS), MacKeller et al. show Black (37%) and Hispanic (21%) MSM reported 
fear of testing positive as a primary reason for not testing at higher rates compared to Whites 
(15%).40 Bond et al. further examined the structural as well as individual-level barriers to HIV 
testing, and the authors found that structural-level measures including having a regular 
healthcare provider and the number of visits to the doctors were important correlates of HIV 
testing.41  
Another important factor that may influence HIV testing may be physician 
recommendation. For example, a number of studies have shown that racial and ethnic 
minorities are less likely to be offered preventive, operative and other services in the healthcare 
setting. Specifically, in their study on socially assigned race and healthcare discrimination, 
MacIntosh et al. found that racial and ethnic minorities who were perceived socially as white 
were more likely to receive preventive vaccinations and less likely to report perceived 
healthcare discrimination.42 So, it is possible that individuals who perceive differential treatment 
in a healthcare setting are less likely to receive important screening tests because of physician 
failure to offer and encourage testing.  
 
2.3 Pathway for racial discrimination influencing health  
Jones defines racial discrimination as “differential actions towards others by race that 
can influence health”.43 The research literature suggests that racial discrimination can influence 
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health through multiple pathways. Most discrimination research has focused on the 
psychosocial pathway, which posits that discrimination is a stressor that affects the 
neuroendocrine, autonomic, and immune systems.44 Changes in various biological systems 
leads to physiological changes that influence cellular decay.44 Individuals also often engage in 
high-risk coping behaviors that relieve stress but also put them at risk for poor health. Most of 
the research along this pathway has shown a positive relationship between racial discrimination, 
poor mental and physical health outcomes and negative health behaviors.10 11-13 Specifically, 
discrimination is related to elevated blood pressure,6,7 higher levels of depression,8 increased 
smoking behaviors,9 and increased alcohol use.45  
Another pathway through which discrimination has been posited to affect health is 
through access to individual and macro-level resources.11 On the individual level, Crawford et al 
argues that discrimination can lead to more high-risk social relationships that influence disease 
transmission and fewer health promoting social relationships that would advocate for healthier 
behaviors.46 On the macro level, a very large body of literature has examined discrimination 
through an institutional lens whereby policies and community efforts segregate minorities from 
healthy residential environments.16,47,48 Williams defines racial residential segregation as “the 
physical separation of races by enforced residence in certain areas.”47. Racially segregated 
neighborhoods have been shown to have inadequate education, fewer recreational facilities, 
higher levels environmental hazards, fewer jobs, and limited access to medical care, which 
restrict the residents’ ability to practice effective heath behaviors and result in negative health 
consequences among marginalized racial groups.47 While we believe all of the pathways of 
discrimination are important and may have an influence on HIV testing behavior, this thesis 
argues that racial discrimination acts as a psychosocial stressor, which affects health, and 
results in coping behaviors that are negatively associated with HIV testing.  
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2.4 Racial Discrimination and HIV Testing Behavior 
While theoretical frameworks of discrimination-health relationships18 suggests that 
discrimination may influence HIV testing behavior, research examining the influence of racial 
discrimination on HIV testing behaviors is mixed.10 Irvin et al. examined the relationship 
between healthcare-specific racial discrimination and HIV testing among black men who have 
sex with men (MSM).49 Over 80% of participants who reported healthcare-specific discrimination 
had been tested for HIV within the last year and healthcare-specific racial discrimination was 
positively associated with HIV testing [OR=1.6 (95% confidence interval: 1.1, 2.4)]. In this study, 
healthcare specific racial discrimination was operationalized as unfair treatment due to race for 
the participant, a friend, family member, or someone they knew. Therefore, healthcare specific 
discrimination may have overestimated individual experiences of discrimination, which would 
positively bias the exposure estimate resulting in an attenuated relationship between 
discrimination and HIV testing. Furthermore, the measure included all healthcare-specific 
discrimination experiences over the lifetime and therefore the temporal relationship between 
discrimination and HIV testing could not be assessed. In another clinic-based study, Ford et al. 
examined the association between perceived everyday racism and HIV testing behavior among 
373 Blacks seeking sexually transmitted disease (STD) testing in the deep South. This study 
showed that more than 90% of participants perceived everyday racism, which was associated 
with higher odds of receiving an HIV test [OR=1.64 (1.07,2.52)] .10 Since this study was limited 
to a sample of Blacks, the relative difference in HIV testing with other racial and ethnic groups is 
unclear. Moreover, this study operationalized discrimination using the everyday discrimination 
scale, which captures chronic, routine, and relatively minor experiences of racial discrimination.8 
The items on the scale capture the day-to-day experiences of discrimination including 
differential treatment compared to others, being treated with less respect than others, receiving 
poorer quality service than others, viewed as not smart, viewed as dishonest, viewed as less 
than, called names/insulted, and being threatened or harassed.(Table I).8 While Krieger et al. 
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showed that the everyday racism scale has strong validity and reliability11, it is possible that 
experiences of racial discrimination in and of itself are not linked to HIV testing because it is not 
these everyday experiences that affect behaviors, but an individuals’ response and ability to 
recover from these negative experiences in order to maintain a healthy state. In other words, if 
an individual has a racialized experience that they are unaware of or they are able to cope with 
the experience to “move on,” we might not expect this to affect their health. On the other hand, if 
an individual has a racialized experience that causes them emotional or even physical strain 
and they have difficulty “moving on” from a negative experience, we would expect this 
rumination and perseverative cognition to affect their health. 
Given that few studies have examined the relationship between discrimination and HIV 
testing, but a small piece of evidence counter intuitively suggests a positive relationship where 
experiences of discrimination predict higher HIV testing uptake, we will examine how reactions 
to race-based treatment affect HIV testing behaviors. This examination adds to the existing 
literature by 1) examining how an individuals’ response to racial discrimination, not just an 
experience of racial discrimination alone, measured by the Reactions to Race module 
influences HIV testing behavior and 2) assessing this research question in a racially diverse 
sample for which we will be able to understand differences in experiences of reactions to racial 
discrimination and its relationship to HIV among non-Hispanic Whites, non-Hispanic Blacks and 
Hispanics.  
2.5 Reactions to Race-based treatment and HIV testing 
The Reactions to Race module captures personal experience and how an individual 
responded to differential treatment because of their race. This module has undergone several 
rounds of cognitive testing, field-testing, and pilot testing when it was launched by the CDC in 
2002. Since being piloted, the six measures in the module have been operationalized 
individually and in combination with each other to assess the impact of race-based treatment on 
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various health behaviors and health outcomes.20,22,50 Reliability and validity testing of the 
Reactions to Race based measures reveal that the module had adequate face validity, but may 
be limited in its reliability because this measure has not been replicated in another sample.19,22  
In this analysis, we examine the association between Reactions to Race-based 
treatment and HIV testing behaviors among non-Hispanic White, non-Hispanic Black, and 
Hispanic individuals; and examine if the association between Reactions to Race-based 
treatment and HIV testing is modified by race/ethnicity using data from the 2012 Behavioral Risk 
Factor Surveillance System (BRFSS). We hypothesized that non-Hispanic White, non-Hispanic 
Black, and Hispanics who report Reactions to Race-based treatment would have significantly 
lower HIV testing prevalence and heterogeneity of effect between race and ethnicity and 
Reactions to Race-based treatment with respect to HIV testing will be present. Specifically, 
Non-Hispanic Blacks and Hispanic individuals who report Reactions to Race-based treatment 
will have a significantly lower HIV testing prevalence compared to non-Hispanic Whites. 
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Chapter III-Manuscript 
INTRODUCTION 
Racial and ethnic disparities in HIV transmission, infection, and treatment are pervasive. 
In the United States, Blacks and Hispanics are disproportionately infected with HIV compared to 
Whites and have the highest percentage of undiagnosed HIV infections.1,2 Specifically, 15% of 
Blacks and 15% of Hispanics have the undiagnosed HIV infections compared to 11% of 
Whites.2 HIV testing plays a critical role in preventing HIV transmission, as individuals with HIV 
who know they are positive are more likely to initiate HIV treatment and less likely to participate 
in high-risk sexual or drug use behaviors.3 Although HIV testing rates are higher among Blacks 
and Hispanics compared to Whites, 17% of Blacks and 17% of Hispanics compared to 13% of 
Whites are unaware of their HIV status.2 This suggests a continued need for improving HIV 
testing and prevention efforts among Black and Hispanic communities.4  
Previous studies have described barriers to HIV testing.38,51 The most commonly cited 
barriers to HIV testing that may influence racial and ethnic disparities in HIV include HIV 
exceptionalism or the fear of a HIV positive status being different from other diseases, lack of 
access to care, and misconceptions about HIV risk.8 40,51,52 Research has also suggested that 
racial discrimination may be an important factor that influences decisions to engage in positive 
health behaviors as well as opportunities to receive health-promoting resources such as 
screening tests.8,11,15,22 Racial discrimination acts as a system of differential treatment based on 
phenotypic race which structures opportunities and resources that influence health and health 
behaviors.19 The discrimination literature has implicated racial discrimination as a fundamental 
determinant of racial and ethnic inequities in health,19  Racial discrimination incites physiological 
stressors as a response to racialized experiences that increases negative coping behaviors that 
might put one at risk for HIV transmission while decreasing positive health behaviors such as 
HIV testing.16 Previous literature has used various measures to capture racial discrimination, but 
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many of these measures do not capture whether or not an individual perceives these 
experiences as problematic. This study measures racial discrimination using the Reactions to 
Race module of the Behavioral Risk Factor Surveillance System (BRFSS) which captures an 
individual’s experience of differential treatment based on race and whether or not an individual 
perceives that they experience a physical or emotional response to a racialized experience. 
Given the pervasiveness of discrimination in the United States,19 it is possible that individuals 
who experience discrimination are primed for these negative encounters and thus they have no 
effect on the individual psychologically or physiologically.53 Given this, we examined the 
relationship between racial discrimination and HIV testing behaviors using the Reactions to 
Race module, which measures an individuals’ response to racial discrimination, rather than just 
an experience of racial discrimination alone. We also determined whether any relationship 
between Reactions to Race-based treatment and HIV testing is differential by Whites, Blacks, 
and Hispanic participants in the Behavioral Risk Surveillance Survey (BRFSS).  We 
hypothesized that Whites, Blacks, and Hispanics who reported Reactions to Race-based 
treatment would have lower HIV testing prevalence and heterogeneity of effect between race 
and ethnicity and Reactions to Race-based treatment with respect to HIV testing will be present. 
Specifically, Blacks and Hispanic individuals who report Reactions to Race-based treatment will 
have a significantly lower HIV testing prevalence compared to Whites. 
 
METHODS 
Data Source  
The BRFSS is a nationally representative, state-level, random-digit dialed telephone, 
multistage-cluster sampling survey administered by the Centers of Disease Control and 
Prevention (CDC). A detailed account of the study procedures, sampling and instruments have 
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been described elsewhere.54 But, in brief, the survey collects data on non-institutionalized, adult 
(≥18 years) residents in the United States.55 BRFSS includes three sections to ascertain 
information on health-related risk behaviors, chronic health conditions and use of preventive 
services: the core section, optional modules, and additional questions from each state. We used 
the 2012 survey, when the Reactions to Race module was administered as an optional module 
to capture the experience of differential treatment based on race in a population-based sample 
of Arizona and Wyoming.  
Sample Population 
The sample population included non-Hispanic Whites (n=11,007), non-Hispanic Blacks 
(n=146), and Hispanics (n=1388) aged ≥ 18 years who responded to at least one of the 
questions in the Reactions to Race module. In 2012, 13,579 participants aged ≥18 in Arizona 
(n=7,306) and Wyoming (n=6,273) responded to the survey. Due to small sample sizes, 
participants who identified as Asian, Native Hawaiian or other Pacific Islander, American Indian 
or Alaska native, or some Other race or Multiracial were excluded from this analysis (n=600). 
Outcome – HIV testing 
HIV testing was assessed via self-report through a question on the BRFSS core 
questionnaire. Participants were asked, “Have you ever been tested for HIV?” Available 
responses were yes, no, don’t know, and refused. For this analysis, we only included those who 
reported yes or no. 
Exposure – Reactions to Race 
Six questions were administered on the Reactions to Race optional module to assess 
personal experiences of differential treatment based on race and the Reactions to Race-based 
treatment. We investigated four of the six measures. The questions and responses include: 
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1. Race Consciousness: “How often do you think about your race? Would you say never, 
once a year, once a month, once a week, once a day, once an hour, or constantly?”  
2. Healthcare treatment: “Within the past 12 months when seeking health care, do you feel 
your experiences were worse than, the same as, or better than for people of other 
races?” Individuals who responded that they only encountered people of the same race 
and did not seek healthcare within the past 12 months were excluded from the entire 
analysis. 
3. Physical symptoms: “Within the past 30 days, have you experienced any physical 
symptoms, for example, a headache, and upset stomach, tensing of your muscles or a 
pounding heart, as a result of how you were treated based on your race?” Possible 
response categories included yes, no, and don’t know/not sure. 
4. Emotional symptoms: “Within the past 30 days, have you felt emotionally upset, for 
example angry, sad, or frustrated, as a result of how you were treated based on your 
race?” Possible response categories included yes, no, and don’t know/not sure. 
We assessed the association between each of the four questions separately with the 
outcome (ever tested for HIV). Responses for race consciousness were recoded as always 
(constantly, once an hour, or once a day), sometimes (once a week or once a month), never 
(once a year or never) and don’t know. For the healthcare treatment responses, worse than 
other races/better than others was included in the worse than other races category. Emotional 
and physical symptoms due to race-based treatment were analyzed as collected. In addition to 
assessing each question independently, we also created a composite score of all experiences 
of race-based treatment and responses using all four questions based on previous studies in 
the literature.21 The Reactions to Race composite score was categorized into three categories: 
1) no experiences of reactions to race based treatment (respondents who never thought about 
race, experienced equal or better treatment at work & healthcare, and experienced no emotional 
nor physical symptoms); 2) one experience of reactions to race based treatment (respondents 
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who reported ≥1 of the following: thinking about their race sometime or always, experiencing 
worse healthcare or work treatment, even if the respondent felt treatment was better than some, 
or experiencing emotional or physical  symptoms); and 3) ≥2 experiences of Reactions to Race 
based treatment (respondents reporting ≥2 affirmative responses to any of the five Reactions to 
Race based treatment measures: thinking about race, experienced worse healthcare treatment, 
experienced worse work treatment, suffered emotional symptoms or physical symptoms). Those 
who responded “don’t know/not sure” to all Reactions to Race measures were categorized 
separately as “unknown number of experiences”. 
Potential confounders  
Consistent with previous literature, the following characteristics were included in the 
analysis as potential confounders of the association between HIV testing behaviors and 
Reactions to Race measures: age, sex, marital status, education, income, employment, health 
insurance, and high risk behaviors.10,22 Age was grouped into four categories: 18-39, 40-49, 50-
64, and ≥ 65. Sex was analyzed as collected in the survey (male and female). Marital status 
was categorized as married/ member of unmarried couple, divorced/ separated/widowed, and 
single. Educational attainment was recoded as less than or equal to high school, high school or 
GED, and college or more. Income level was recoded as earning less than $35,000, $35,000-
$75,000, and greater $75,000 per year. Employment status was classified as employed, 
unemployed, and retired. Health insurance was categorized as yes or no. HIV risk was 
assessed in the BRFSS by asking respondents if any of the following high risk situations apply 
to them: used intravenous drugs, treated for a sexually transmitted or venereal disease, given or 
received money or drugs in exchange for sex, or had anal sex without a condom in the past 
year. Respondents were not asked about each of these risk behaviors individually.  
Effect modifier 
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Race/ethnicity was included in the analysis as a potential effect modifier in the 
relationship between Reactions to Race based treatment and HIV testing. Race/ethnicity was 
classified as mutually exclusive categories including non-Hispanic White, non-Hispanic Black, 
and Hispanic. For our analysis, all respondents who identified as White or Black (African-
American) were Non-Hispanic. Respondents who identified as Hispanic could be of any race 
and were classified as Hispanic regardless.  
Statistical Analysis 
We assessed the bivariate association between Reaction to Race-based measures and 
HIV testing using chi-square analysis. For AIM I, descriptive characteristics including frequency 
percentages and standard errors56 for categorical variables were calculated for the entire 
population. We then calculated the prevalence of HIV testing overall for selected characteristics 
and the Reactions to Race measures. In the bivariate analysis, we performed chi-square tests 
to assess the unadjusted relationship between select characteristics with HIV testing and the 
Reactions to Race composite score. For inclusion in the adjusted model, we considered 
statistically significant characteristics (P< .05) in addition to the characteristics that could be 
acting as confounders in the casual pathway between experiences of racial discrimination and 
HIV testing. For AIM II, descriptive statistics for selected characteristics were calculated, and the 
prevalence of HIV testing by race and ethnicity was calculated for selected characteristics. 
Multivariable logistic regression model was used to calculate the odds ratios and 95% 
confidence intervals between Reactions to Race measures and HIV testing behavior after 
adjusting for significant characteristics identified in the bivariate analysis. Interaction terms 
between each reaction to race-based treatment measure with race and ethnicity were assessed 
to determine heterogeneity of effect.  The significance of the statistical interaction terms was 
assessed at an alpha level of 0.05. We stratified the adjusted relationship between Reactions to 
Race and HIV testing by race and ethnicity to show the effect of Reactions to Race on HIV 
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testing within each racial and ethnic group after adjusting for confounders. All analyses were 
performed using SAS 9.3. To account for the complex survey design, the analysis was weighted 
using procedures in SAS procedures PROC SURVEYLOGISITC, PROC SURVEYMEANS AND 
PROC SURVEYFREQ, which account for dependencies between observations.  
  
RESULTS 
Descriptive characteristics of all respondents of the Reactions to Race module are 
shown in Table II. Overall, most participants in the sample were over 65 (40%), female (59%), 
White (88%), married (58%), lived in Arizona (53%), had at least a high school education (35%), 
earned less than $35,000 per year (36%), were employed (45%), had health insurance (88%), 
and had no HIV risk (93%), and reported no experiences of Reactions to Race based-treatment 
(53%). About 21% reported ever being tested for HIV, and 18.9% of the population had one or 
more experiences of Reaction to Race based-treatment (Table 2). 
Overall the prevalence of the Reactions to Race at least one experience of racial 
discrimination was higher among 18-39 (44%) compared to those over 65 (p=<.0001), those 
who were married (63%) compared to single (p=<.0001), those who had health insurance (88%) 
compared to the uninsured, and those who had no HIV risk (93%) compared to those with HIV 
risk (Table 2).  The prevalence of HIV testing was significantly higher among participants age 
18-39 (50%) compared to those aged 65 and older (p=<.0001), those with health insurance 
(78%) compared to those without insurance (p=0.132), those who were employed (60%) 
compared to those who were unemployed (p= <.0001), those with no HIV risk (92%) compared 
to those with HIV risk (p=<.0001) , and those with some college experience (37%) compared to 
those with college or more (p=0.038). (Table 3). There were no significant differences in HIV 
testing by participant gender, health insurance status, emotional or physical symptoms from 
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racialized experiences. Significantly more participants who received HIV testing had 1 or more 
experience of Reactions to Race based-treatment (p=0.004) compared to those who had  
In the adjusted analysis (Table 4), we used the Reactions to Race composite score to 
calculate the odds of seeking HIV testing for those who had 1 experience of race-based 
treatment and 2 or more experiences compared to those who had no experience. One 
experience of Reactions to Race based treatment was significantly related to HIV testing 
(OR=1.37; 95% CI: 1.08-1.75) and 2 or more experiences (OR=1.37; 95% CI: 0.90-2.08) was 
marginally related to HIV testing compared to those who had no experiences of Reactions to 
Race-based treatment. Respondents who were Black (OR=2.60; 95% CI: 1.44-4.68) compared 
to Whites, those who were divorced, separated, or widowed (OR=1.52; 95% CI: 1.17-2.0) 
compared to those who were married or a member of an unmarried couple, those with college 
or more education (OR=1.43; 95% CI: 1.09-1.88) compared to less than high school education, 
and those with HIV risk (OR=4.31; 95% CI: 2.33-7.97) compared to those with no HIV risk had 
an increased odds of HIV testing. Additionally, respondents who reported experiencing physical 
symptoms (OR=1.89; 95% CI: 1.12-3.21) compared to no physical symptoms or worse 
treatment in the healthcare setting (OR=2.09; 95% CI: 1.09-4.03) as a result of Reactions to 
Race based-treatment compared to the same treatment were significantly more likely to report 
HIV testing.   
With respect to the race-stratified analysis (Table 6), the sample had a majority of 
Whites (88%) followed by Hispanics (11%) and Blacks (1%). The prevalence of HIV testing was 
higher among Blacks (61.5%) and Hispanics (33.3%) compared to Whites (31.6%) (P-
value=<.0001; Table 5).  The prevalence of 1 or more Reactions to Race based treatment 
among those tested for HIV was significantly higher among Blacks (56.2%) and Hispanics 
(62.6%) compared to Whites (32.5%). Significant differences in HIV testing by education level, 
marital status, health insurance, income, and HIV risk were seen by race and ethnicity. 
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Specifically, Hispanics (61%) who had a less than high school education had a higher 
prevalence of HIV testing compared to Whites (32%) and Blacks (34%). Compared to Whites 
(58%) and Hispanics (53%), Blacks (40%) who were married or a member of an unmarried 
couple had a lower prevalence of HIV testing. Among those who had health insurance, Whites 
(90%) had the highest prevalence of HIV testing compared to Blacks (81%) and Hispanics 
(71%). HIV testing prevalence was significantly lower among Whites (33%) who earned less 
than $35,000 per year compared to Blacks (51%) and Hispanics (55%) who earned less than 
$35,000. Furthermore, prevalence of HIV testing among Blacks (5%) who had HIV risk was 
higher compared to Whites (1%) and Hispanics (3%).  
The results of the interaction term testing revealed that no interaction between race and 
Reactions to Race-based treatment measures was observed for HIV testing behavior. All 
analyses were repeated for each individual Reactions to Race-based treatment measures and 
the Reactions to Race composite score.  
In the racially stratified adjusted analysis, Whites who had 1 experience of Reactions to 
Race based treatment (OR=1.37; CI: 1.07- 2.83) or 2 or more experiences (OR=1.74; CI: 1.06-
1.78) of differential treatment were significantly more likely to seek HIV testing compared to 
those who had no experiences. Blacks who experienced Reaction to Race based treatment 
were significantly more likely to ever be tested for HIV for measures of Reactions to Race 
based-treatment except emotional symptoms compared to Blacks who did not experience the 
treatment (Table 6). Specifically, Blacks who had physical symptoms due to race-based 
treatment (OR=8.23; CI: 1.58-42.7) were more likely to seek HIV testing compared to those who 
had no experiences. Furthermore, Blacks who experienced worse treatment in the healthcare 
setting (OR=13.9; CI: 2.06-94.3) compared to those who had the same treatment in healthcare. 
Although insignificant Blacks who always thought about their race (OR=2.52; CI: 0.46-13.8) 
compared to Blacks who never thought about their race were more likely to be HIV tested. The 
 
 
24 
 
odds of HIV testing among Whites (OR=2.03; CI: 0.61-6.72) and Hispanics (OR=1.00; CI: 0.61-
6.50) were not significantly different for Whites and Hispanics, respectively, who had worse 
treatment in the healthcare setting. Hispanics (OR=0.75 CI: 0.82-3.75) and Whites (OR=0.78 CI: 
0.35-1.70) who had emotional symptoms due to race based-treatment were insignificantly less 
likely to be tested for HIV compared to Hispanics and Whites, respectively, who did not have 
emotional symptoms. White (OR=0.73; CI:0.35-1.54) and Hispanic (OR=0.76; CI 0.57-1.79)  
respondents who reported better treatment than other races in the healthcare setting were also 
insignificantly less likely to get tested for HIV compared to Whites and Hispanics, respectively, 
who had the same treatment. The odds of HIV testing among Blacks (OR=2.50; CI: 0.29-21.3) 
who had 2 or more experiences of Reactions to Race based treatment was not significantly 
higher compared to Blacks who did reported no experiences.  
 
DISCUSSION 
The results of this study revealed that experiences of Reactions to Race-based 
treatment was associated with increased rates of HIV testing across race and ethnic groups, 
and HIV testing behaviors was increased in Whites who experienced race-based treatment 
compared to Whites who had no experiences. We hypothesized that measures of Reactions to 
Race based treatment was negatively associated with HIV testing prevalence across the total 
population, however our findings did not support this hypothesis. The results indicated that 
respondents who had an experience of Reactions to Race based-treatment in healthcare, 
responded emotionally or physically to differential treatment, or constantly thought about their 
race had a higher HIV testing prevalence among the total population. For example, respondents 
who experienced worse treatment than other races in the healthcare setting were more likely to 
receive HIV testing compared to those who had the same or better treatment.  
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In a cross-sectional analysis of BRFSS, Hausmann and colleagues examined the 
association between perceived discrimination measured by the Reactions to Race measures 
and use of preventive health care services including receiving a flu shot, mammogram, Pap test, 
blood stool test, and sigmoidoscopy/colonoscopy.57 In the adjusted model, the results revealed 
that utilization of preventive health care services was lower among those who had experiences 
of racial discrimination in health care. The findings of our study are inconsistent with 
Hausmann’s findings in that that those who had experiences of racial discrimination were more 
likely to receive HIV testing.  
Although a positive association between Reactions to Race based treatment and HIV 
testing appears counterintuitive and does not support theoretical frameworks, other studies 
have shown similar findings.49,58 For example, Borrell and colleagues investigated the 
association between discrimination with smoking, alcohol consumption, and physical activity.59 
In a racially stratified analysis, Blacks who experienced moderate or high racial discrimination 
were more physically active than Blacks who reported no discrimination. A possible explanation 
could be that racial and ethnic minorities who respond to differential treatment based on race 
challenge the negative experience and engage in healthier outcomes and behaviors such as  
seeking HIV testing.10 So it is possible that the stressors related to racial discrimination that 
result in emotional and/ or physical symptoms could serve as motivation to combat the 
differential treatment and in turn seek HIV testing. It is conceivable that Reactions to Race 
based treatment is protective of health protective. In the CARDIA study among young Blacks 
and Whites, Krieger and colleagues found that Blacks who notice racial discrimination in their 
social environment and challenge it could have healthier outcomes than those who do not 
engage; therefore perceived racial discrimination may not be inherently detrimental if responses 
to those experiences are proactive. 58 
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 The results of our stratified analysis suggests that there are not differences in 
experiences of Reactions to Race based treatment with respect to HIV testing within 
racial/ethnic groups. After adjustment for selected covariates, Blacks who had physical 
symptoms and had worse healthcare treatment had a higher HIV testing prevalence compared 
to Blacks who did not have physical symptoms and the same healthcare treatment, however 
these results had unstable odd ratios and 95% confidence intervals likely due to small sample 
sizes. Despite the unstable results, this finding is consistent with Ford et al. clinic-based study, 
which examined perceiving everyday racism and HIV testing behaviors among Blacks. The 
results revealed a higher odds of HIV testing among Blacks who perceived racism compared to 
those who did not experience race based treatment.10On the other hand, Blacks who always 
thought about their race were more likely to receive HIV testing, however this result was not 
statistically significant. On the other hand, Blacks and Hispanics who reported emotional 
symptoms due to differential treatment in healthcare were insignificantly less likely to receive 
HIV testing. This finding demonstrates the potential negative association between experiences 
of racial discrimination and HIV testing.  
In another study, Lillie-Blanton and colleagues found that racial and ethnic groups often 
experience the healthcare system differently, and racial discrimination acts a barrier to 
accessing adequate healthcare services in these communities. Our results were not consistent 
with this study. We found the odds of testing for HIV among Blacks who experienced differential 
treatment in healthcare were significantly higher compared to those who did not experience 
differential treatment. Irvin and colleagues also examined the relationship between healthcare-
specific racial discrimination and HIV testing among Black MSM, and found that over 80% of 
participants who reported healthcare-specific discrimination had been tested for HIV within the 
last year and healthcare-specific racial discrimination was positively associated with HIV testing 
[OR=1.6(1.1,2.4)]. Our study is consistent with the findings by Irvin and colleagues although 
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these studies operationalized racial discrimination differently. Irvin and colleagues 
operationalized healthcare specific racial discrimination as unfair treatment due to race for the 
participant, a friend, family member, or someone they knew, compared to our study, which 
assessed individual experiences of Reactions to Race based-treatment.  
Measurement of racial discrimination is a critically important issue for the future of racial 
discrimination assessment.18 There is great variability in how discrimination is assessed, yet no 
one measure has been identified as the standard measure. As demonstrated in Table I, the 
length, content, and language of the discrimination measures vary for each scale. Therefore, 
future research should systematically review existing methodologies used to measure 
discrimination to develop a more consistent measure to be used in discrimination literature. This 
measure(s) should comprehensively assess discrimination by identifying individual events and 
the accumulation of discriminatory events over a lifetime, while also capturing an individual’s 
response to differential treatment, Development of a more consistent measure will add to the 
discrimination literature by providing a comprehensive measure to better understand of 
differential treatment can influence the health of various populations.  
Furthermore, the results also revealed that Whites who had 2 or more experiences of 
Reactions to Race based treatment were significantly more likely to test for HIV compared to 
those who had no experience. It is possible that Whites do not consider notions of culture and 
history when thinking about their race; therefore they may associate being discriminated against 
with being a marginalized group. In turn, this notion may result in an over or underestimation in 
the number of experiences of racial discrimination. This finding suggests that reports of racial 
discrimination among Whites specifically need to be further examined. Among Whites, those 
who received better treatment than other races in the healthcare setting were less likely to seek 
HIV testing compared to those with the same treatment. This finding may be seen because 
respondents who are treated better do not believe they are at risk for HIV and in turn seeking 
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testing at lower rates.  Hispanics who had emotional symptoms due to Reactions to Race based 
treatment were less likely to be tested for HIV compared to those who did not experience 
emotional symptoms. However, Hispanics who had a physical symptom due to Reactions to 
Race based treatment compared to those who did not were more likely to be tested. These 
findings suggest that  physical and emotional responses to race-based treatment results in 
differences  in HIV testing behaviors among Hispanics, and underscores the need for additional 
research on the manifestation of responses to stress.  
The study has several limitations. First, due to the cross-sectional nature of the study, 
we are unable to establish temporality. Moreover, because we examine lifetime HIV testing, we 
are unable to establish temporality between HIV testing and any of the Reactions to Race 
measures. We attempted to assess past year HIV testing (Appendix I), but due to small sample 
sizes, we were unable to determine whether Reactions to Race based measures preceded HIV 
testing. Second, the self-report nature of the data could result in an overestimation of HIV 
testing and over or under-estimation of Reactions to Race based treatment. Third, the state-
specific data was weighted to be nationally representative of the given states, it is not 
generalizable to all states in the US. Fourth, small sample sizes among the racial and ethnic 
minority groups presented a challenge for obtaining stable estimates in the adjusted analyses 
among Black and Hispanics.  
Despite the limitations, our study had several strengths. Specifically, the sample 
population was large enough to include several potential confounders. To our knowledge, this is 
the first study to examine the relationship between race based treatment and HIV testing across 
races using the Reactions to Race module.  
CONCLUSION 
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 Our study revealed that Reaction to Race based treatment is associated with increased 
HIV testing. Further, the odds of HIV testing among those who experienced Reactions to Race 
based treatment differed by race and ethnicity.  This positive relationships between Reactions 
to Race-based treatment and HIV testing is heightened among Black participants who have 
expereinced physical symptomscompared to those who did not have physical symptoms and 
Whites who had 1 or more experiences of Reactions to Racebased treatment compared to 
those who had no expereinces. Understanding whether HIV testing motivations vary by race 
and ethnicity is important for understanding differences in HIV. Given that Blacks 
counterintuitively were more likely to be tested if they experienced a racialized experience, we 
need to better understand the pathways that link discrimination with HIV testing by exploring 
whether discriminaiton results in proactive health responses. We must consider the potential 
postive association in which stress due to racial discrimination can infleucne an individual’s 
health behaviors.To improve inequities in HIV among racial and ethnic minorities, more 
research is needed to understand the settings, populations, and outcomes in which Reactions 
to Race based treatment is detrimental versus protective.  
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Table I. Measures of Racial Discrimination employed in previous literature 
Discrimination Survey 
Instrument Name 
(Author) 
Goal of survey instrument Survey Items 
The Major and 
Everyday 
Discrimination Scale 
(Williams) 
Two part scale that captures 
major experiences of unfair 
treatment as well as the chronic, 
routine and relatively minor 
experiences unfair treatment in 
everyday life 
 Everyday experience of discrimination items: 
treated with less courtesy, treated with less 
respect, receiving poorer service, viewed as not 
smart, viewed as dishonest, viewed as less than, 
called names/insulted, and being threatened or 
harassed 
 Major experiences of discrimination: ever unfairly 
fired or denied promotion, ever unfairly not hired, 
ever unfairly treat by police, ever unfairly 
discouraged from continuing education, ever 
unfairly prevented from moving, unfairly denied 
bank loan, received inadequate services 
compared to others 
 A follow up question is asked to capture the main 
reason for the experiences (i.e. gender, race, 
age, ancestry, religion etc.)  
Experiences of 
Discrimination(EOD) 
measure (Krieger) 
Measures the frequency of having 
experienced discrimination based 
on race, ethnicity, or color and the 
individuals’ response to the 
experiences 
 Ever discriminated against: at school; getting a 
job; at work; getting a house; receiving medical 
care; interacting with police/courts; or in a public 
setting. 
 Response to unfair treatment: “accept as fact of 
life” or “try to do something about it” 
Reactions to Race 
Module (BRFSS) 
Measures individual experiences 
of racial discrimination, 
embodiment of the racial 
discrimination, and the 
individuals’ reaction to race-based 
treatment 
 How often does the individual think about their 
race; experiences of unfair treatment in the 
workplace and health care setting, and physical 
(e.g. headache, upset stomach, pounding heart) 
or emotional (e.g. angry, sad, frustrated) 
responses to unfair racial treatment 
Perceived Racism 
Scale (McNeilly) 
Multidimensional scale which 
measures the frequency of 
perceived experiences of racism 
among African-Americans and 
assesses the emotional and 
behavioral coping responses to 
racism 
 43 items on the frequency of exposure to racial 
discrimination on the job; academic settings; 
public settings; racist statements 
 8 items on emotional responses (e.g. feeling 
angry, sad) and behavioral coping responses 
(e.g. speaking up, forgetting it, getting violent, 
praying) to perceived racism 
 
 
 
 
Participant Characteristics
Total               
n =12,541 %
No experience    
% (SE)
1 experience 
% (SE)
2 or more 
experiences 
% (SE)
Unknown 
experiences   
% (SE) P-value
Age Group (years)
   18-39 2040 16.4 34 .3 (1.41) 44.4 (2.22) 46.0 (4.78) 65.3 (2.99)
    40-49 1393 11.2 15.7 (1.03) 18.0 (1.68) 21.7 (3.97) 12.7 (2.13)
    50-64 3968 32.0 27.5 (1.12) 23.5 (1.71) 25.7 (3.87) 14.7 (1.89)
    ≥ 65 5013 40.4 22.53 (0.87) 14.0 (1.12) 6.6 (1.58) 7.32 (1.14)
Sex 
   Male 5104 40.7 44.2 (1.34) 54.4 (2.15) 50.3 (4.7) 56.0 (3.5)
   Female 7437 59.3 55.9 (1.35) 45.6 (2.15) 49.7 (4.7) 44.0 (3.5)
Race
   White 11007 87.8 83.3 (1.28) 54.4 (2.23) 33.8 (3.9) 71.0 (3.6)
   Black 146 1.2 2.7 (0.63) 4.6 (0.95) 11.6 (3.3) 4.27 (2.00)
   Hispanic 1388 11.1 14.0 (1.19) 40.9 (2.3) 54.5 (4.6) 24.7 (3.43)
Marital Status 
    Married/ Member of unmarried couple7108 57.6 62.5 (1.3) 54.7 (2.2) 52.2 (4.7) 45.8 (3.4)
    Divorced/ Separated/Widowed 3974 31.9 20.2 (0.9)  18.6 (1.5) 14.6 (2.4) 14.7 (2.0)
    Single  1312 10.5 17.3 (1.19) 26.7 (2.12) 33.2 (4.8) 39.5 (3.53)
State
     Arizona 6584 52.5 87.6 (0.32) 95.0 (0.35) 96.8 (0.60) 94. 4 (0.72)
     Wyoming 5957 47.5 12.4 (0.32) 5.00 (0.35) 3.21 (0.60) 5.61 (0.72)
Education Level
     ≤ High School 4428 35.4 34.9 (1.34) 41.4 (2.2) 61.4 (4.37) 43.3 (3.63)
     Some College 3941 31.5 40.0 (1.35) 34.7 (2.13) 25.5 (3.87) 32.5 (3.15)
     ≥ College 4131 33.1 25.1 (1.00) 24.0 (1.55) 13.1 (2.6) 24.2 (2.45) 
Health Insurance
      Yes 10967 87.7 86.5 (0.98) 78.5 (1.91) 61.8 (4.78) 78.7 (3.09)
      No 1537 12.3 13.5 (0.98) 21.5 (1.91) 38.2 (4.78) 21.2 (3.10)
Employment Status
     Employed 5544 44.5 52.9 (1.35) 60.0 (2.14) 45.1 (4.60) 61.0 (3.40)
     Unemployed 2568 20.6 26.4 (1.32) 27.3 (2.06) 47.2 (4.73) 31.6 (3.40)
     Retired 4358 35.0 20.7 (0.84) 12.9 (1.11) 7.7 (2.3) 7.41 (1.20)
Income
     Less than $35,000 4523 36.1 31.3 (1.25) 42.6 (2.19) 57.2 (4.64) 48.3 (3.53)
     $35,00- $75,000 3415 27.2 27.8 (1.16) 24.7 (1.75) 21.3 (3.79) 20.8 (2.42)
     Greater than $75,000 2791 22.3 28.6 (1.27) 23.3 (1.83) 6.8 (1.71) 19.8 (2.63)
     DK/Refused/Missing 1812 14.5 12.2 (0.89) 9.4 (1.37) 14.6 (3.72) 11.1 (2.32)
HIV Riskc
    Yes 177 1.4 2.86 (0.47) 4.21 (0.94) 3.49 (1.58) 3.97 (1.37)
     No 11,673 93.3 97.1 (0.47) 95.8 (0.95) 96.5 (1.58) 87.4 (2.84)
HIV testing
     Yes 2669 21.3 30.7 (1.28) 39.6 (2.15) 39.6 (4.56) 35.5 (3.80)
      No 8887 70.9 69.3 (1.28) 60.4 (2.15) 60.4 (4.56) 64.5 (3.38)
<.0001
<.0001
<.0001
Table 2.  Prevalence of Reactions to Race composite score by sample characteristics and Reaction to Race 
measures, Behavioral Risk Factor Surveillance System, Arizona & Wyoming, 2012 a b
cHIV Risk was assessed by measuring if the individual had engaged in any of the following behaviors that put them at risk for 
HIV transmission: used intravenous drugs; received treatment for a sexually transmitted disease in the past year; received 
money or drugs in exchange for sex in the past year, or had anal sex without a condom in the past year.
<.0001
0.0003
<.0001
<.0001
<.0001
<.0001
0.0031
<.0001
aPercentages reported are weighted
bParticipants who were missing HIV testing were excluded from analysis
 
 
 
 
Participant Characteristics
Age Group (years)
   18-39 49.74 (1.77) 33.36 (1.22)
    40-49 20.74 (1.40) 13.63 (0.86)
    50-64 23.14 (1.37) 26.20 (0.94)
    ≥ 65 6.38 (0.61) 26.81 (0.81)
Sex 
   Male 51.27 (1.76) 47.76 (1.17)
   Female 48.73 (1.76) 52.24 (1.17)
Race
   White 66.08 (1.88) 71.29 (1.23)
   Black 7.67 (1.19) 2.40 (0.39)
   Hispanic 26.25 (1.78) 26.31 (1.23)
Marital Status 
    Married/ Member of unmarried couple 52.45 (1.77) 59.28 (1.15)
    Divorced/ Separated/Widowed 20.10 (1.21) 20.48 (0.80)
    Single  27.45 (1.73) 20.24 (1.10)
State
     Arizona 92.08 (0.37) 90.1 (0.22)
     Wyoming 7.92 (0.37) 9.00 (0.22)
Education Level
     ≤ High School 37.80 (1.81) 42.48 (1.20)
     Some College 36.73 (1.72) 35.46 (1.12)
     ≥ College 25.48 (1.30) 22.06 (0.80)
Health Insurance
      Yes 77.55 (1.62) 80.44 (1.06)
      No 22.45 (1.62) 19.56 (1.06)
Employment Status
      Employed 60.31 (1.75) 48.45 (1.17)
     Unemployed 32.18 (1.73) 27.69 (1.15)
     Retired 7.5 (0.69) 23.86 (0.77)
Income
      Less than $35,000 41.27 (1.78) 37.8 (1.15)
     $35,00- $75,000 23.90 (1.45) 24.99 (0.93)
     Greater than $75,000 25.00 (0.93) 21.04 (0.95)
      DK/Refused/Missing 9.62 (1.04) 16.20 (0.92)
Table 3. Prevalence of HIV testing by sample characteristics and Reaction 
to Race measures, Behavioral Risk Factor Surveillance System, Arizona & 
Wyoming, 2012 a b
<.0001
0.099
<.0001
0.0002
Ever tested     
% (SE)
Never tested     
% (SE) 
P-value
0.043
0.038
0.132
<.0001
<.0001
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participant Characteristics
HIV Risk
    Yes 6.91 (0.93) 1.43 (0.30)
     No 91.97 (1.06) 97.94 (0.37)
    DK/Refused/Missing 1.12 (0.55) 0.62 (0.22)
     Yes 7.93 (1.07) 6.03 (0.71)
     No 82.14 (1.41) 84.76 (0.93)
     DK/Refused/Missing 9.93 (1.05) 9.21 (0.69)
     Yes 5.28 (0.94) 3.31 (0.45)
     DK/Refused/Missing 10.61 (1.15) 9.39 (0.70)
Health care treatment
     Worse 5.70 (0.93) 2.54 (0.40)
     Better 8.57 (0.91) 12.08 (0.70)
     DK/Refused/Missing 18.25 (1.35) 23.04 (0.970
Race Consciousness 
     Never 50.61 (1.77) 58.04 (1.18)
     Sometimes 22.26 (1.44) 17.29 (0.96)
     Always 15.67 (1.52) 13.80 (0.96)
     DK/Refused/Missing 11.46 (1.12) 10.87 (0.72)
Reactions to Race Composite Score  
      No experiences 40.49 (1.70) 45.71 (1.15)
      1 experience 27.96 (1.63) 21.30 (1.03)
      ≥2 experiences 7.74 (1.07) 5.88 (0.69)
      Unknown experiences 8.93 (1.01) 8.09 (0.66)
0.207
0.054
<.0001
0.006
0.0004
Table 3. Prevalence of HIV testing by sample characteristics and 
Reaction to Race measures, Behavioral Risk Factor Surveillance 
System, Arizona & Wyoming continued, 2012 a b
Ever tested     % 
(SE)
Never tested     
% (SE) 
P-value
<.0001
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OR 95% CI OR 95% CI
Participant Characteristics
Race Consciousness 
   Never 1.00 1.00
   Sometimes 1.45 (1.15-1.83) 1.26 (0.99-1.62)
  Always 1.31 (0.97-1.78) 1.26 (0.87-1.82)
Emotional Symptoms
  Yes 1.12 (0.73-1.75) 1.02 (0.64-1.623)
   No 1.00 1.00
Physical Symptoms
  Yes 1.91 (1.17-3.12) 1.82 (1.08-3.06)
   No 1.00 1.00
Healthcare Treatment
   Worse 2.53 (1.34-4.79) 2.09 (1.08-4.03)
   Same 1.00 1.00
   Better 0.68 (0.52-0.89) 0.85 (0.63-1.15)
Reactions to Race Composite Score
   No experiences 1.00 1.00
   1 experience 1.48 (1.20-1.83) 1.37 (1.08-1.75)
   ≥ 2 experiences 1.49 (1.00-2.20) 1.37 (0.90-2.08)
HIV Testing
Table 4.  Unadjusted and adjusted odds ratio (95% CI) of the 
relationship between sample characteristics and Reaction to Race 
variables with HIV Testing, Behavioral Risk Factor Surveillance 
System, Arizona & Wyoming, 2012 d e
dAnalysis adjusted for age, race, marital status, state, income, and HIV risk
eOdds ratios reported in the table are weighted to reflect known proportions of 
age, race/ethnicity, gender, geographic region, and other known 
characteristics of the population 
Adjusted ORUnadjusted OR
 
 
 
 
 
n % n % n %
Participant Characteristics
Age Group (years)
   18-39 1576 14.47 43 30.5 421 30.53
    40-49 1110 10.19 28 19.86 255 18.49
    50-64 3549 32.58 38 26.95 381 27.63
    ≥ 65 4659 42.77 32 22.7 322 23.35
Sex 
   Male 4482 40.72 73 50 549 39.55
   Female 6525 59.28 73 50 839 60.45
Marital Status 
    Married/ Member of unmarried couple 6385 58.36 59 40.41 736 53.33
    Divorced/ Separated/Widowed 3528 32.25 52 35.62 394 28.55
    Single  1027 9.39 35 23.97 250 18.12
State
     Arizona
     Wyoming 5320 48.33 125 85.62 1139 82.06
5687 51.67 21 14.38 249 17.94
Education Level
     ≤ High School 3529 32.15 51 35.42 848 61.45
     Some College 3558 32.42 47 32.64 336 24.35
     ≥ College 3889 35.43 46 31.94 196 14.2
Health Insurance
      Yes 9869 89.92 118 80.82 980 70.86
      No 1106 10.08 28 19.18 403 29.14
Employment Status
      Employed 4808 43.9 76 52.41 660 48.07
     Unemployed 2058 18.79 39 26.9 471 34.3
     Retired 4086 37.31 30 20.69 242 17.63
Income
      Less than $35,000 3684 33.47 74 50.68 765 55.12
     $35,00- $75,000 3116 28.31 34 23.29 265 19.09
     Greater than $75,000 2618 23.78 25 17.12 148 10.66
      DK/Refused/Missing 1589 14.44 13 8.9 210 15.13
 Table 5.  Descriptive characteristics all respondents of Reactions to Race Module for selected 
characteristics by race/ ethnicity, Behavioral Risk Factor Surveillance System, Arizona & Wyoming, 
2012 
P-value
<.0001
0.05
<.0001
<.0001
<.0001
Whites
(n=11007)
Blacks
(n=11007)
Hispanics
(n=1388)
<.0001
<.0001
<.0001
 
 
 
 
n % n % n %
Participant Characteristics
HIV Risk
    Yes 135 1.23 7 4.79 35 2.52
     No 10308 93.65 132 90.41 1233 88.83
    DK/Refused/Missing 564 5.12 7 4.79 120 8.65
Emotional Symptoms 
     Yes 243 2.21 20 13.7 135 9.73
     No 9784 88.89 110 75.34 1054 75.94
     DK/Refused/Missing 980 8.9 16 10.96 199 14.34
Physical Symptoms
     Yes 150 1.36 8 5.48 95 6.84
     No 9886 89.92 119 81.51 1089 78.46
     DK/Refused/Missing 971 8.82 19 13.01 204 14.7
Healthcare Treatment
     Worse 210 1.91 10 6.85 55 3.96
     Same 6846 62.2 88 60.27 840 60.52
     Better 1256 11.41 13 8.9 164 11.82
     DK/Refused/Missing 2695 24.48 36 23.97 329 23.7
Race Consciousness 
     Never 7917 71.93 50 34.25 509 36.67
     Sometimes 1470 13.36 74 16.44 241 17.36
     Always 405 3.68 125 34.93 398 28.67
     DK/Refused/Missing 1215 11.04 146 14.38 240 17.29
Reactions to Race Composite Score
      No experiences 6161 70.42 37 31.9 395 34.05
      1 experience 1501 17.16 43 37.07 456 39.31
      ≥2 experiences 210 2.4 21 18.1 128 11.03
      Unknown experiences 877 10.02 15 12.93 181 15.6
HIV Testing
     Ever tested 2232 20.28 70 47.95 367 26.44
     Never tested 7935 72.09 65 44.52 887 63.9
     DK/Missing 840 7.63 11 7.53 134 9.65
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
 Table 5.  Descriptive characteristics all respondents of Reactions to Race Module for selected 
characteristics by race/ ethnicity, Behavioral Risk Factor Surveillance System, Arizona & Wyoming,  
continued 2012 
Whites Blacks Hispanics
P-value
(n=11007) (n=11007) (n=1388)
 
 
 
Particpant characterisitcs
Ever 
tested 
%
Never 
tested  
% OR 95% CI
Ever 
tested  
%
Never 
tested  
% OR 95% CI
Ever 
tested  
%
Never 
tested  
% OR 95% CI
Overall prevalence 31.64 68.36 61.52 38.48 33.25 66.75
Emotional Symptoms 
     Yes 4.64 2.48 0.78 (0.35-1.70) 18.04 15.84 0.99 (0.13-7.91) 13.29 14.77
     No 85.40 88.24 1.00 72.14 75.44 1.00 76.84 76.16 0.83 (0.40-1.72)
     DK/Refused/Missing 9.96 9.27 9.83 8.71 9.87 9.07 1.00
Physical Symptoms
     Yes 2.67 1.34 1.72 (0.77-3.84) 11.69 7.02 8.23 (1.58-42.7) 10.00 8.31 1.75 (0.82-3.75)
     No 87.58 89.30 1.00 76.32 81.97 1.00 77.66 82.38 1.00
     DK/Refused/Missing 9.75 9.36 11.99 11.00 12.34 9.31
Healthcare Treatment
     Worse 4.50 2.29 2.03 (0.61-6.72) 16.92 3.33 13.90 (2.06-94.3) 5.46 3.12 1.99 (0.61-6.50)
     Same 68.95 62.23 1.00 55.14 55.62 1.00 67.36 63.27 1.00
     Better 8.89 11.93 0.73 (0.35-1.54) 9.58 13.37 2.27 (0.50-10.2) 7.48 12.37 0.76 (0.37-1.58)
     DK/Refused/Missing 17.66 23.54 18.36 27.68 19.71 21.24
Race Consciousness 
     Never 59.76 69.07 1.00 34.21 37.40 1.00 32.35 30.02 1.00
     Sometimes 23.26 15.64 1.01 (0.55-1.84) 13.46 13.93 1.72 (0.14-21.4) 22.31 22.08 1.01 (0.55-1.86)
     Always 5.82 4.49 1.01 (0.56-1.81) 39.04 41.97 2.52 (0.46-13.8) 33.63 36.47 1.01 (0.57-1.79)
     DK/Refused/Missing 11.16 10.81 13.29 6.70 11.70 11.44
Reactions to Race Composite Score  
      No experiences 57.21 66.74 1.00 32.24 40.60 1.00 26.76 29.83 1.00
      1 experience 27.51 19.65 1.37 (1.07-2.83) 33.12 30.04 2.57 (0.36-18.3) 46.83 44.03 1.30 (0.76-2.21)
      ≥2 experiences 4.94 3.27 1.74 (1.06-1.78) 23.09 20.67 2.50 (0.29-21.3) 15.81 16.95 1.10 (0.52-2.30)
      Unknown experiences 10.34 10.33 11.54 8.68 10.58 9.19
Table 6.  Prevalence and odds ratio  (95% Confidence Intervals) of HIV testing by sample characteristics and Reaction to Race measures by race/ 
ethnicity, Behavioral Risk Factor Surveillance System, Arizona & Wyoming, 2012  f g
Whites Blacks Hispanics
fAll analysis adjusted for age, and marital status. The model for Whites was additionally adjusted for sex, education level, health insurance, employment, HIV risk and 
income. The model for Blacks was additionally adjusted for employment status. The model for Hispanics was additionally adjusted for sex and HIV risk.
gOdds ratios reported in the table are weighted samples to reflect known proportions of age, race/ethnicity, gender, geographic region, and other known 
characteristics of the population
 
 
 
 
Tested in the 
past year %
Not tested in 
past year % P-value
Ever HIV 
testing %
Never tested for 
HIV % P-value
Not tested in 
past year %
Never tested 
for HIV% P-value
Participant Characteristics
Age Group (years)
   18-39 73.81 46.03 52.76 33.36 46.03 33.36
    40-49 11.4 24.43 21.27 13.63 24.42 13.62
    50-64 11.25 24.19 21.05 26.2 24.19 26.2
    ≥ 65 3.55 5.35 4.62 26.81 5.35 26.81
Sex 
   Male 58.73 49.45 51.71 47.76 49.45 47.76
   Female 41.27 50.55 48.29 52.24 50.55 52.24
Race
   White 61.48 66.47 65.25 71.29 66.47 71.29
   Black 11.5 7.45 8.44 2.4 7.45 2.4
   Hispanic 57.02 26.09 26.31 26.21 26.09 26.31
Marital Status 
    Married/ Member of unmarried couple 37.21 55.93 51.4 59.28 55.93 59.28
    Divorced/ Separated 18.75 17.59 17.86 12.4 17.59 12.4
    Widowed 0.992 1.95 1.72 8.08 1.95 8.08
    Single  43.08 24.53 29.02 20.24 24.53 20.24
State
     Arizona 93.53 91.51 92 91 91.51 91
     Wyoming 6.47 8.49 8 9 8.49 9
Education Level
     ≤ High School 36.17 36.83 36.67 42.48 36.83 42.48
     Some College 40.06 36.59 37.44 35.46 36.59 35.46
     ≥ College 23.79 26.58 25.89 22.06 26.58 22.06
Health Insurance
      Yes 74.92 78.31 77.49 80.43 78.31 80.44
      No 25.08 21.69 22.51 19.56 21.69 19.56
0.078
<.0001
0.407 0.142
<.0001
0.038
0.328
<.0001
0.072
0.656 0.0250.015
0.077
<.0001
<.0001
<.0001
0.496
<.0001
<.0001
0.42
0.336
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Appendix 1. Comparison of descriptive statistics of participants not tested in the past year and participants never tested for HIV, Behavioral Risk Factor 
Surveillance System, Arizona & Wyoming, 2012
 
 
 
 
 
Tested in the past 
year %
Not tested in past 
year % P-value
Ever HIV testing 
%
Never tested for 
HIV % P-value
Not tested in 
past year %
Never tested for 
HIV% P-value
Participant Characteristics
Employment Status
      Employed 61.56 62.55 62.31 48.45 62.55 48.45
     Unemployed 34.69 31.02 31.91 27.69 31.02 27.69
     Retired 3.75 6.44 5.78 23.5 6.44 23.86
Income
      Less than $35,000 51.01 38.66 41.67 37.75 38.66 37.75
     $35,00- $75,000 23.87 24.88 24.63 25 24.88 25
     Greater than $75,000 17.36 27.52 25.04 21.04 27.52 21.04
      DK/Refused/Missing 7.76 8.95 8.66 16.2 8.94 16.2
HIV Risk
    Yes 12.24 5.72 7.3 1.44 5.72 1.44
     No 86.4 93.47 91.74 97.94 93.47 97.94
Emotional Symptoms 
     Yes 9.26 6.9 7.47 6.03 6.9 6.03
     No 77.05 84.08 82.37 82.37 84.08 84.76
     DK/Refused/Missing 13.69 9.02 10.16 9.21 9.02 9.2
Physical Symptoms
     Yes 5.36 5.05 5.12 3.3 5.05 3.31
     No 81.01 84.87 83.93 87.31 84.87 87.31
     DK/Refused/Missing 13.62 10.09 10.95 9.38 10.09 9.38
Healthcare Treatment
     Worse 6.36 5.71 5.87 2.54 5.71 2.54
     Same 64.02 69.37 68.07 62.35 69.37 62.37
     Better 9.97 7.66 8.22 12.08 7.66 12.08
     DK/Refused/Missing 19.65 17.25 17.84 23.04 17.25 23.04
0.618 <.0001 <.0001
0.261 <.0001
<.0001
0.02 <.0001 <.0001
0.088 <.0001 0.0002
0.144 0.367 0.218
0.538 0.077 0.206
Appendix 1. Comparison of descriptive statistics of participants not tested in the past year and participants never tested for HIV, Behavioral Risk 
Factor Surveillance System, Arizona & Wyoming, 2012 continued
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Tested in the past 
year %
Not tested in past 
year % P-value
Ever HIV testing 
%
Never tested for 
HIV % P-value
Not tested in 
past year %
Never tested for 
HIV% P-value
Participant Characteristics
Race Consciousness 
     Never 13.56 15.49 15.02 13.8 15.49 13.8
     Sometimes 22.79 23.96 23.68 17.29 23.96 17.29
     Always 48.556 50.53 50.05 58.04 50.53 58.04
     DK/Refused/Missing 15.09 10.02 11.25 10.87 10.02 10.87
Reactions to Race Composite 
Score  
      No experiences 45.04 47.37 46.81 56.44 47.37 56.44
      1 experience 32.68 34.23 33.85 26.3 34.23 26.3
      ≥2 experiences 8.79 8.76 8.76 7.27 8.76 7.27
      Unknown experiences 13.49 9.65 10.58 9.99 9.65 9.99
0.677 0.002 0.007
0.383 0.002 0.005
Appendix 1. Comparison of descriptive statistics of participants not tested in the past year and participants never tested for HIV, Behavioral Risk 
Factor Surveillance System, Arizona & Wyoming, 2012 continued
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